Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders

Psychopathology

Volumn 42, Issue 6, 2009, Pages 350-360

  Dekker, N ^a   Linszen, D H ^a   De Haan, L ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cannabis; Motivation; Psychosis; Psychotic disorders; Reasons; Schizophrenia; Subjective effects; Substance use

Indexed keywords

AFFECT; CANNABIS ADDICTION; COPING BEHAVIOR; DYSPHORIA; HUMAN; PSYCHOSIS; REVIEW; SELF REPORT; SOCIAL STATUS; SOCIALIZATION;

HUMANS; MARIJUANA ABUSE; MARIJUANA SMOKING; MOTIVATION; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SELF MEDICATION;

EID: 70049087393     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000236906     Document Type: Review

References (61)

1. Hambrecht M, Hafner H: Substance abuse and the onset of schizophrenia. Biol Psychiatry 1996; 40: 1155-1163.
2. Cantwell R, Brewin J, Glazebrook C, Dalkin T, Fox R, Medley L, Harrison G: Prevalence of substance misuse in first-episode psychosis. Br J Psychiatry 1999; 174: 150-153.
3. Van Mastrigt S, Addington J, Addington D: Substance misuse at presentation to an early psychosis program. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 69-72.
4. Barnes TR, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM: Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry 2006; 188: 237-242.
5. Green B, Young R, Kavanagh D: Cannabis use and misuse prevalence among people with psychosis. Br J Psychiatry 2005; 187: 306-313.
6. Linszen DH, Dingemans PM, Lenior ME: Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994; 51: 273-279.
7. Caspari D: Cannabis and schizophrenia: results of a follow-up study. Eur Arch Psychiatry Clin Neurosci 1999; 249: 45-49.
8. Buhler B, Hambrecht M, Loffler W, Van der Heiden W, Hafner H: Precipitation and determination of the onset and course of schizophrenia by substance abuse - a retrospective and prospective study of 232 population- based first illness episodes. Schizophr Res 2002; 54: 243-251.
9. Van Os J, Bak M, Hanssen M, Bijl RV, De Graaf R, Verdoux H: Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002;156:319-327.
10. Negrete JC, Knapp WP, Douglas DE, Smith WB: Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol Med 1986; 16: 515-520.
11. D'Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper TB, Krystal JH: Delta- 9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry 2005; 57: 594-608.
12. Mueser KT, Drake RE, Wallach MA: Dual diagnosis: a review of etiological theories. Addict Behav 1998; 23: 717-734.
13. Blanchard JJ, Brown SA, Horan WP, Sherwood AR: Substance use disorders in schizophrenia: review, integration, and a proposed model. Clin Psychol Rev 2000; 20: 207-234.
14. Degenhardt L, Hall W, Lynskey M: Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 2003; 71: 37-48. (Pubitemid 36734857)
15. Degenhardt L, Hall W: Is cannabis use a contributory cause of psychosis? Can J Psychiatry 2006; 51: 556-565. (Pubitemid 44338229)
16. Gregg L, Barrowclough C, Haddock G: Reasons for increased substance use in psychosis. Clin Psychol Rev 2007; 27: 494-510.
17. Henquet C, Murray R, Linszen D, Van Os J: The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005; 31: 608-612.
18. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G: Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-328.
19. Khantzian EJ: The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985; 142: 1259-1264.
20. Khantzian EJ: The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 1997; 4: 231-244.
21. Dixon L, Haas G, Weiden P, Sweeney J, Frances A: Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophr Bull 1990; 16: 69-79.
22. Green B, Kavanagh DJ, Young RM: Reasons for cannabis use in men with and without psychosis. Drug Alcohol Rev 2004; 23: 445-453.
23. Test MA, Wallisch LS, Allness DJ, Ripp K: Substance use in young adults with schizophrenic disorders. Schizophr Bull 1989; 15: 465-476.
24. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ: Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 1991; 148: 224-230.
25. Warner R, Taylor D, Wright J, Sloat A, Springett G, Arnold S, Weinberg H: Substance use among the mentally ill: prevalence, reasons for use, and effects on illness. Am J Orthopsychiatry 1994; 64: 30-39.
26. Baigent M, Holme G, Hafner RJ: Self-reports of the interaction between substance abuse and schizophrenia. Aust NZ J Psychiatry 1995; 29: 69-74.
27. Mueser KT, Nishith P, Tracy JI, DeGirolamo J, Molinaro M: Expectations and motives for substance use in schizophrenia. Schizophr Bull 1995; 21: 367-378.
28. Addington J, Duchak V: Reasons for substance use in schizophrenia. Acta Psychiatr Scand 1997; 96: 329-333.
29. Fowler IL, Carr VJ, Carter NT, Lewin TJ: Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998; 24: 443-455.
30. Gearon JS, Bellack AS, Rachbeisel J, Dixon L: Drug use behavior and correlates in people with schizophrenia. Addict Behav 2001; 26: 51-61.
31. Spencer C, Castle D, Michie PT: Motivations that maintain substance use among individuals with psychotic disorders. Schizophr Bull 2002; 28: 233-247.
32. Goswami S, Singh G, Mattoo SK, Basu D: Courses of substance use and schizophrenia in the dual-diagnosis patients: is there a relationship? Indian J Med Sci 2003; 57: 338-346.
33. Schofield D, Tennant C, Nash L, Degenhardt L, Cornish A, Hobbs C, Brennan G: Reasons for cannabis use in psychosis. Aust NZ J Psychiatry 2006; 40: 570-574.
34. Lambert M, Haasen C, Mass R, Krausz M: Konsummuster und Konsummotivation des Suchtmittelgebrauchs bei schizophrenen Patienten (Consumption pattern and motivation for the use of psychotropic substances in schizophrenics). Psychiatr Prax 1997; 24: 184-189.
35. Busquets E, Torrens M, Soler A, Farre M, Bulbena A: Differences in the subjective effects of drugs in patients with a first psychotic episode: preliminary results. Actas Esp Psiquiatr 2005; 33: 10-25.
36. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. DSM-III, ed 3. Washington, American Psychiatric Association, 1980.
37. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, DSM-III-R, ed 3, rev. Washington, American Psychiatric Association, 1987.
38. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. DSM IV, ed 4. Washington, American Psychiatric Association, 1994.
39. Dilling H, Mombour W, Schmidt MH: International Classification of Mental Diseases (German ed). Bern, Huber, 1991, chapt V (F).
40. Rolfe T, McGorry P, Cocks J, Yuen H, Longley T, Plowright D: Cannabis use in first episode psychosis, incidence and short-term outcome. Inaugural Cannabis and Psychosis Conference Final Papers, Melbourne, 1999.
41. Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie (Assessment and documentation of psychopathology). Manual zur Dokumentation psychiatrischer Befunde (Manual for Documentation of Psychiatric Diagnosis), ed 4. Berlin, Springer, 1981.
42. Cooper ML: Motivations for alcohol use among adolescents: development and validation of a four-factor model. Psychol Assess 1994; 6: 117-128.
43. Cooper ML, Russel M, Skinner JB, Windle M: Development and validation of a threedimensional measure of drinking motives. Psychol Assess 1992; 4: 123-132.
44. Schafer J, Brown SA: Marijuana and cocaine effect expectancies and drug use patterns. J Consult Clin Psychol 1991; 59: 558-565.
45. Lamas X, Farré M, Llorente M, Cami J: Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI). Drug Alcohol Depend 1994; 35: 203-209.
46. Spitzer RL, Endicott J, Robins E: Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35: 773-782.
47. Annis HM, Graham JM, Davis CS: Inventory of Drug Taking Situations (IDS). Toronto, Addiction Research Foundation Ontario, 1989.
48. Arsenault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE: Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325: 1212-1213.
49. Stefanis NC, Delespaul P, Henquet C, Bakoula C, Stefanis CN, Van Os J: Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004; 99: 1333-1341.
50. Fergusson DM, Horwood LJ, Ridder EM: Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 2005; 100: 354-366.
51. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, Van Os J: Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005; 330: 11-15.
52. Ferdinand RF, Sondeeijker F, Van der Ende J, Selten JP, Huizink A, Verhulst FC: Cannabis use predicts future psychotic symptoms, and vice versa. Addiction 2005; 100: 612-618.
53. Cox WM, Klinger E: A motivational model of alcohol use. J Abnorm Psychol 1988; 97: 168-180.
54. Henquet C, Van Os J, Delespaul P, Campo J, Myin-Germeys I: Psychosis reactivity to cannabis use in daily life: an experience sampling study; in Henquet C: Ecogenetic Studies of Cannabis as a Cause of Psychosis (PhD thesis). Maastricht, Maastricht University, 2006, chapt 8, pp 123-142.
55. Stirling J, Barkus EJ, Nabosi L, Irshad S, Roemer G, Schreudergoidheijt B, Lewis S: Cannabis-induced psychotic-like experiences are predicted by high schizotypy: confirmation of preliminary results in a large cohort. Psychopathology 2008; 41: 371-378.
56. Newcomb MD, Chou C, Bentler PM, Huba GJ: Cognitive motivations for drug use among adolescents: longitudinal tests of gender differences and predictors of change in drug use. J Couns Psychol 1988; 35: 426-438.
57. Simons J, Correia CJ, Carey KB, Borsari E: Validating a five-factor marijuana motives measure: relations with use, problems, and alcohol motives. J Couns Psychol 1998; 45: 265-273.
58. Simons J, Correia CJ, Carey KB: A comparison of motives for marijuana and alcohol use among experienced users. Addict Behav 2000; 25: 153-160.
59. Chabrol H, Duconge E, Casas C, Roura C, Carey KB: Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology. Addict Behav 2005; 30: 829-840.
60. Zvolensky MJ, Vujanovic AA, Bernstein A, Bonn-Miller MO, Marshall EC, Leyro TM: Marijuana use motives: a confirmatory test and evaluation among young adult marijuana users. Addict Behav 2007; 32: 3122-3130.
61. Green B, Kavanagh D, Young R: Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev 2003; 22: 453-460.